Results 291 to 300 of about 457,294 (313)

Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial

Lancet Oncology, The, 2015
Lee S Schwartzberg, Rudolph M Navari
exaly  

Nausea, Vomiting, and Retching: Complex Problems in Palliative Care

Ca-A Cancer Journal for Clinicians, 2001
exaly  

Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon‐like peptide‐1 receptor agonists: A systematic analysis of published clinical trials

Diabetes, Obesity and Metabolism, 2017
Juris J Meier, Michael A Nauck
exaly  

Update on the Management of Postoperative Nausea and Vomiting

Drugs, 2013
Anthony L Kovac
exaly  

Understanding, recognizing, and managing toxicities of targeted anticancer therapies

Ca-A Cancer Journal for Clinicians, 2013
exaly  

Management of Chemotherapy-Induced Nausea and Vomiting

Drugs, 2013
Rudolph M Navari
exaly  

Epidemiology, Clinical Characteristics, and Associations for Rome IV Functional Nausea and Vomiting Disorders in Adults

Clinical Gastroenterology and Hepatology, 2019
Imran Aziz, Ami D Sperber, Magnus Simrén   +2 more
exaly  

Delayed Nausea and Vomiting Continue to Reduce Patients' Quality of Life After Highly and Moderately Emetogenic Chemotherapy Despite Antiemetic Treatment

Journal of Clinical Oncology, 2006
exaly  

Evidence-based analysis of risk factors for postoperative nausea and vomiting

British Journal of Anaesthesia, 2012
exaly  

Nausea/Vomiting

2009
openaire   +1 more source